These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity. Vesikari T, Ruuska T, Green KY, Flores J, Kapikian AZ. Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741 [Abstract] [Full Text] [Related]
3. Rotavirus: the major etiologic agent of severe infantile diarrhea may be controllable by a "Jennerian" approach to vaccination. Kapikian AZ, Flores J, Hoshino Y, Glass RI, Midthun K, Gorziglia M, Chanock RM. J Infect Dis; 1986 May; 153(5):815-22. PubMed ID: 3009632 [No Abstract] [Full Text] [Related]
13. Duration of protection of pentavalent rotavirus vaccination in Nicaragua. Patel M, Pedreira C, De Oliveira LH, Umaña J, Tate J, Lopman B, Sanchez E, Reyes M, Mercado J, Gonzalez A, Perez MC, Balmaceda A, Andrus J, Parashar U. Pediatrics; 2012 Aug; 130(2):e365-72. PubMed ID: 22753550 [Abstract] [Full Text] [Related]
17. Recent advances in development of a rotavirus vaccine for prevention of severe diarrheal illness of infants and young children. Kapikian AZ, Flores J, Vesikari T, Ruuska T, Madore HP, Green KY, Gorziglia M, Hoshino Y, Chanock RM, Midthun K. Adv Exp Med Biol; 1991 Aug; 310():255-64. PubMed ID: 1667066 [No Abstract] [Full Text] [Related]
18. Development of candidate rotavirus vaccines. Bishop RF. Vaccine; 1993 Aug; 11(2):247-54. PubMed ID: 8382418 [Abstract] [Full Text] [Related]
20. Protection of Peruvian children against rotavirus diarrhea of specific serotypes by one, two, or three doses of the RIT 4237 attenuated bovine rotavirus vaccine. Lanata CF, Black RE, del Aguila R, Gil A, Verastegui H, Gerna G, Flores J, Kapikian AZ, Andre FE. J Infect Dis; 1989 Mar; 159(3):452-9. PubMed ID: 2536789 [Abstract] [Full Text] [Related] Page: [Next] [New Search]